ALNYLAM PHARMACEUTICALS, INC. Net Income 2008-2025 | ALNY
Beta
What is net income?
Net income can be defined as the company's total earnings or profit. It is calculated as revenues minus all expenses including cost of goods sold, operating expenses, interest, and taxes.
What is ALNYLAM PHARMACEUTICALS, INC.'s current net income?
ALNYLAM PHARMACEUTICALS, INC. (ALNY) annual net income for 2025 was $313.7M, a 212.79% increase from 2024. ALNYLAM PHARMACEUTICALS, INC. net income for the quarter ending December 31, 2025 was $147.2M.
What was ALNYLAM PHARMACEUTICALS, INC.'s net income in 2024?
ALNYLAM PHARMACEUTICALS, INC. annual net income for 2024 was $-278.2M, a 36.82% increase from 2023.
What was ALNYLAM PHARMACEUTICALS, INC.'s net income in 2023?
ALNYLAM PHARMACEUTICALS, INC. annual net income for 2023 was $-440.2M, a 61.08% increase from 2022.
Net Income History
Year-over-year comparison from 10-K annual reports
Key Statistics
Trend Direction
Growing
CAGRN/A
FY2020
$-858.3M
→
FY2025
$313.7M
080910111213141516171819202122232425
5 years selected
Net Income History
| Period | Value | Change | Source |
|---|---|---|---|
| FY2025 | $313.7M | +212.8% | 10-K |
| FY2024 | $-278.2M | +36.8% | 10-K |
| FY2023 | $-440.2M | +61.1% | 10-K |
| FY2022 | $-1.13B | -32.6% | 10-K |
| FY2021 | $-852.8M | +0.6% | 10-K |
| FY2020 | $-858.3M | +3.1% | 10-K |
| FY2019 | $-886.1M | -16.4% | 10-K |
| FY2018 | $-761.5M | -55.1% | 10-K |
| FY2017 | $-490.9M | -19.7% | 10-K |
| FY2016 | $-410.1M | -41.4% | 10-K |
| FY2015 | $-290.1M | +19.5% | 10-K |
| FY2014 | $-360.4M | -303.9% | 10-K |
| FY2013 | $-89.2M | +15.8% | 10-K |
| FY2012 | $-106.0M | -83.9% | 10-K |
| FY2011 | $-57.6M | -32.5% | 10-K |
| FY2010 | $-43.5M | +8.6% | 10-K |
| FY2009 | $-47.6M | -81.3% | 10-K |
| FY2008 | $-26.2M | - | 10-K |
Company: ALNYLAM PHARMACEUTICALS, INC.Ticker: ALNYSector: HealthcareIndustry: Pharmaceutical PreparationsView company profile →